Prescribe FIT, a leading full-service remote patient monitoring and virtual lifestyle health coaching platform tailored for orthopedic practices, has successfully raised $4.8 million in funding. The company aims to revolutionize musculoskeletal (MSK) health by optimizing patients for surgery through personalized lifestyle interventions. With a focus on addressing specific MSK issues related to weight management, Prescribe FIT highlights the importance of targeted lifestyle modifications for improved outcomes post-surgery. Through their innovative approach, Prescribe FIT offers orthopedic practices a comprehensive solution to enhance patient care and drive positive results in musculoskeletal health. The recent funding injection will enable Prescribe FIT to further expand its offerings, strengthen its partnerships within the healthcare industry, and continue driving advancements in remote patient monitoring and virtual health coaching.
Prescribe FIT Secures $4.8M to Revolutionize Orthopedic Health and Wellness
Recently funded 路 $4.8MHealthcare
Get the full Prescribe FIT company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Aisot Technologies
Aisot Technologies is a Zurich-based AI company pioneering advanced, AI-driven investment solutions. Spun out of ETH Zurich in 2021, aisot leverages machine learning, large language models (LLMs), and quantitative methods to deliver precise, real-time investment insights. Its AI Insights Platform empowers asset managers, funds, family offices, and treasuries to anticipate market trends, optimize strategies, and mitigate risk. Recognized across Europe and the U.S., aisot partners with leading financial institutions to redefine quantitative investment management.
$2.5M Seed
today
Dognosis
Dognosis is a deep-tech startup in Bangalore decoding canine cognition to reveal the hidden world of scent. Our vision is a world where we have cracked the olfactory code of disease, making detecting disease as easy as breathing. Our mission is to save lives by detecting disease early and advance humanity towards truly proactive and preventative medicine. Our work revolves around increasing the bandwidth of human-canine collaboration, allowing us to catch the scent of disease at scale. Our first goal is to solve for early cancer detection by pioneering a multi-cancer breath-based test - BreathEasy - that will be ultra-affordable, highly accurate, and super accessible. We're always on the lookout for passionate and ambitious people to work with us. Feel free to say hi to woof@dognosis.tech
